162 related articles for article (PubMed ID: 16705583)
1. Erythema migrans in solid-organ transplant recipients.
Maraspin V; Cimperman J; Lotric-Furlan S; Logar M; Ruzić-Sabljić E; Strle F
Clin Infect Dis; 2006 Jun; 42(12):1751-4. PubMed ID: 16705583
[TBL] [Abstract][Full Text] [Related]
2. The impact of immunosuppression on erythema migrans. A retrospective study of clinical presentation, response to treatment and production of Borrelia antibodies in 33 patients.
Fürst B; Glatz M; Kerl H; Müllegger RR
Clin Exp Dermatol; 2006 Jul; 31(4):509-14. PubMed ID: 16716151
[TBL] [Abstract][Full Text] [Related]
3. Erythema migrans in the immunocompromised host.
Maraspin V; Lotric-Furlan S; Cimperman J; Ruzić-Sabljić E; Strle F
Wien Klin Wochenschr; 1999 Dec; 111(22-23):923-32. PubMed ID: 10666803
[TBL] [Abstract][Full Text] [Related]
4. Development of erythema migrans in spite of treatment with antibiotics after a tick bite.
Maraspin V; Lotric-Furlan S; Strle F
Wien Klin Wochenschr; 2002 Jul; 114(13-14):616-9. PubMed ID: 12422612
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis, treatment, and prognosis of erythema migrans and Lyme arthritis.
Feder HM; Abeles M; Bernstein M; Whitaker-Worth D; Grant-Kels JM
Clin Dermatol; 2006; 24(6):509-20. PubMed ID: 17113969
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of erythema migrans].
Barsić B
Lijec Vjesn; 1999; 121(4-5):148-53. PubMed ID: 10437360
[TBL] [Abstract][Full Text] [Related]
7. Immunoblot analysis of the seroreactivity to recombinant Borrelia burgdorferi sensu lato antigens, including VlsE, in the long-term course of treated patients with erythema migrans.
Glatz M; Fingerle V; Wilske B; Ambros-Rudolph C; Kerl H; Müllegger RR
Dermatology; 2008; 216(2):93-103. PubMed ID: 18216470
[TBL] [Abstract][Full Text] [Related]
8. Clinical relevance of different IgG and IgM serum antibody responses to Borrelia burgdorferi after antibiotic therapy for erythema migrans: long-term follow-up study of 113 patients.
Glatz M; Golestani M; Kerl H; Müllegger RR
Arch Dermatol; 2006 Jul; 142(7):862-8. PubMed ID: 16847202
[TBL] [Abstract][Full Text] [Related]
9. Solitary erythema migrans in children: comparison of treatment with azithromycin and phenoxymethylpenicillin.
Arnez M; Pleterski-Rigler D; Luznik-Bufon T; Ruzić-Sabljić E; Strle F
Wien Klin Wochenschr; 2002 Jul; 114(13-14):498-504. PubMed ID: 12422590
[TBL] [Abstract][Full Text] [Related]
10. Multiple erythema migrans--manifestation of systemic cutaneous borreliosis.
Egberts F; Möller M; Proksch E; Schwarz T
J Dtsch Dermatol Ges; 2008 May; 6(5):350-3. PubMed ID: 18201222
[TBL] [Abstract][Full Text] [Related]
11. Duration of treatment for Lyme borreliosis: time for a critical reappraisal.
Wormser GP; Nowakowski J; Nadelman RB
Wien Klin Wochenschr; 2002 Jul; 114(13-14):613-5. PubMed ID: 12422611
[TBL] [Abstract][Full Text] [Related]
12. [Early-stage lyme borreliosis during pregnancy: treatment in 15 women with erythema migrans].
Hercogová J; Tománková M; Frösslová D; Janovská D
Cesk Gynekol; 1993 Oct; 58(5):229-32. PubMed ID: 8221915
[TBL] [Abstract][Full Text] [Related]
13. Risk of culture-confirmed borrelial persistence in patients treated for erythema migrans and possible mechanisms of resistance.
Hunfeld KP; Ruzić-Sabljić E; Norris DE; Kraiczy P; Strle F
Int J Med Microbiol; 2006 May; 296 Suppl 40():233-41. PubMed ID: 16530006
[TBL] [Abstract][Full Text] [Related]
14. Course of Borrelia burgdorferi DNA shedding in urine after treatment.
Aberer E; Bergmann AR; Derler AM; Schmidt B
Acta Derm Venereol; 2007; 87(1):39-42. PubMed ID: 17225014
[TBL] [Abstract][Full Text] [Related]
15. [Early diagnosis of Lyme borreliosis].
Hofmann H
MMW Fortschr Med; 2006 Jun; 148(25):32, 34, 36. PubMed ID: 16859158
[TBL] [Abstract][Full Text] [Related]
16. [Erythema (chronicum) migrans. The clinical variability of the earliest manifestation of Lyme borreliosis].
Mrowietz U
Dtsch Med Wochenschr; 1996 Aug; 121(31-32):988-93. PubMed ID: 8765403
[No Abstract] [Full Text] [Related]
17. Comparison of Clinical Course and Treatment Outcome for Patients With Early Disseminated or Early Localized Lyme Borreliosis.
Stupica D; Maraspin V; Bogovic P; Ogrinc K; Blagus R; Cerar T; Strle F
JAMA Dermatol; 2018 Sep; 154(9):1050-1056. PubMed ID: 30073319
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic treatment of Lyme borreliosis: what is the evidence?
Dinser R; Jendro MC; Schnarr S; Zeidler H
Ann Rheum Dis; 2005 Apr; 64(4):519-23. PubMed ID: 15769910
[TBL] [Abstract][Full Text] [Related]
19. Lyme borreliosis treatment.
Vanousová D; Hercogová J
Dermatol Ther; 2008; 21(2):101-9. PubMed ID: 18394084
[TBL] [Abstract][Full Text] [Related]
20. [Borrelial erythema of the face].
de Heller-Milev M; Peter O; Panizzon RG; Laffitte E
Ann Dermatol Venereol; 2008 Dec; 135(12):852-4. PubMed ID: 19084697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
